120 related articles for article (PubMed ID: 34147479)
1. Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection.
Adhikari A; Eltahla A; Lloyd AR; Rodrigo C; Agapiou D; Bull RA; Tedla N
J Immunol Methods; 2021 Aug; 495():113087. PubMed ID: 34147479
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
Adhikari A; Abayasingam A; Brasher NA; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd AR; Bull RA; Tedla N
J Med Virol; 2024 Jan; 96(1):e29381. PubMed ID: 38235622
[TBL] [Abstract][Full Text] [Related]
3. Absence of anti-envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977.
Grellier L; Brown D; Power J; Dusheiko G
J Viral Hepat; 1997; 4(6):379-81. PubMed ID: 9430357
[TBL] [Abstract][Full Text] [Related]
4. Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.
Walker MR; Eltahla AA; Mina MM; Li H; Lloyd AR; Bull RA
Viruses; 2020 Jan; 12(1):. PubMed ID: 31936235
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
6. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
[TBL] [Abstract][Full Text] [Related]
8. How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
Brito-Zerón P; Gheitasi H; Retamozo S; Bové A; Londoño M; Sánchez-Tapias JM; Caballero M; Kostov B; Forns X; Kaveri SV; Ramos-Casals M
Arthritis Res Ther; 2015 Sep; 17(1):250. PubMed ID: 26370711
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
[TBL] [Abstract][Full Text] [Related]
11. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
12. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
[TBL] [Abstract][Full Text] [Related]
13. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection.
Rafique S; Idrees M; Ali A; Iqbal M
Mol Biol Rep; 2014 Jun; 41(6):3945-50. PubMed ID: 24566682
[TBL] [Abstract][Full Text] [Related]
14. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
15. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
[TBL] [Abstract][Full Text] [Related]
16. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
17. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic options for HCV infection in the monoclonal antibody era.
Sautto GA; Diotti RA; Clementi M
New Microbiol; 2012 Oct; 35(4):387-97. PubMed ID: 23109006
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
Kobayashi M; Tanaka E; Matsumoto A; Ichijo T; Kiyosawa K
J Gastroenterol Hepatol; 1997 Jan; 12(1):73-6. PubMed ID: 9076628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
